Premium
Ulcerative terminal ileitis after BCG therapy for bladder carcinoma
Author(s) -
Satgé D,
Pommepuy I,
Hassan T,
Goburdhun J,
Flejou JF
Publication year - 2002
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1046/j.1365-2559.2002.01445.x
Subject(s) - ileitis , medicine , ulcerative colitis , etiology , gastroenterology , ileum , enteritis , carcinoma , disease , tuberculosis , terminal ileum , pathology , crohn's disease
Aim: We evaluated the aetiology of ulcerative ileitis in a 77‐year‐old patient receiving BCG therapy for recurring bladder carcinoma. Methods and results: Histological examination, laboratory data and the clinical history allowed us to exclude a classical cause such as Crohn's disease, tuberculosis or ischaemia. The important locoregional reaction suggests a BCG ileitis of the terminal ileum. Intestinal BCG ileitis has been exceptionally described after BCG vaccination. Conclusion: Our observation of ulcerative ileitis indicates that a digestive tract location is possible as a reaction to BCG therapy.